Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 18, 121-134, February 1, 1958]
© 1958 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tobias, C. A.
Right arrow Articles by Huggins, C. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tobias, C. A.
Right arrow Articles by Huggins, C. B.

Pituitary Irradiation with High-Energy Proton Beams A Preliminary Report*

C. A. Tobias, J. H. Lawrence, J. L. Born, R. K. McCombs, J. E. Roberts, H. O. Anger, B. V. A. Low-Beer{dagger} and C. B. Huggins{ddagger}

( Donner Laboratory of Biophysics and Medical Physics, Donner Pavilion, and the Radiation Laboratory, University of California, Berkeley, Calif.)

There has been described a multiple-plane, rotational technic for irradiation of the human pituitary gland with the 340-Mev proton beam from the 184-inch synchrocyclotron. Peak doses of 14,000–30,000 rad at the center of the pituitary have been administered to 26 patients with metastatic breast cancer, and decreased pituitary function and gross and microscopic damage of the pituitary gland have been demonstrated. The most common laboratory findings were depression of I131 uptake by the thyroid and decrease of 24-hour urinary gonadotropins. There was clinical evidence of improvement in a few of the patients treated. Four patients with acute lymphatic leukemia, embryonal dysgerminoma of the testis, chronic lymphatic leukemia and diabetes mellitus, and malignant exophthalmos have also been irradiated, but they are not reported in detail at this time.

* Various phases of this work were supported by the U.S. Atomic Energy Commission, the Donner Foundation, the U.S. Public Health Service, and the California State Cancer Fund.

The present communication is based on AEC Report UCRL 3035, July, 1955.

{dagger} Deceased, September, 1955.

{ddagger} Director, Ben May Laboratory for Cancer Research, University of Chicago.

Received 5/20/57.


This article has been cited by other articles:


Home page
JOURNAL OF THE ICRUHome page
REFERENCES
J. ICRU, December 1, 2007; 7(2): 189 - 210.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1958 by the American Association for Cancer Research.